Pentetreotide

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NamePentetreotide
Drug Alias Name111In-oktreotid111In-octreotide111In-octreotid
ClassificationSmall molecules > Synthetic peptideDiagnostic agent (In vivo)
Mechanisms of ActionSingle-photon emission-computed tomography enhancers
TargetsNot applicable
Therapy Area/IndicationsSmall Cell Lung CarcinomaCentral Nervous System NeoplasmsBreast Neoplasms +[4] 
Global Approved IndicationsSmall Cell Lung CarcinomaCentral Nervous System NeoplasmsBreast Neoplasms +[4] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryRussian Federation
Original Approved Date2007/01/01
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesPharm-Sintez
China Registration ClassN/A

Develop Information

Active CompaniesPharm-Sintez
Inactive CompaniesN/A
Active IndicationsSmall Cell Lung CarcinomaCentral Nervous System NeoplasmsBreast Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeV04
Related LinksN/A